Outset Medical, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Outset Medical, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q3 2024.
  • Outset Medical, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$27.9M, a 39.5% increase year-over-year.
  • Outset Medical, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$141M, a 19.8% increase year-over-year.
  • Outset Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$173M, a 6.04% decline from 2022.
  • Outset Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$163M, a 23.5% decline from 2021.
  • Outset Medical, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$132M, a 8.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$141M -$27.9M +$18.2M +39.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$159M -$34.5M +$9.59M +21.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$169M -$39.9M +$4.03M +9.16% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$173M -$38.6M +$2.84M +6.86% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 -$176M -$46.2M -$5.4M -13.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$170M -$44M -$207K -0.47% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$170M -$44M -$7.08M -19.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$163M -$41.4M -$212K -0.51% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 -$163M -$40.8M -$10.3M -33.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$152M -$43.8M -$13.6M -45.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$139M -$36.9M -$6.87M -22.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$132M -$41.2M -$9.19M -28.7% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 -$123M -$30.5M +$11.8M +28% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$135M -$30.2M -$3.7M -14% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$131M -$30M -$9.38M -45.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$121M -$32M -$12.6M -64.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-22
Q3 2020 -$109M -$42.3M -$26.9M -175% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$82M -$26.5M -$9.48M -55.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$72.5M -$20.7M -$4.23M -25.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$68.3M -$19.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$15.4M Jul 1, 2019 Sep 30, 2019 10-K 2021-03-22
Q2 2019 -$17M Apr 1, 2019 Jun 30, 2019 10-K 2021-03-22
Q1 2019 -$16.4M Jan 1, 2019 Mar 31, 2019 10-K 2021-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.